EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

From data to evidence: the evolving role of observational studies and target trial emulation in regulatory decision-making

Maurizio Polignano, Ruggero Lasala, Romina Giannini, Andrealuna Ucciero, Alessia Romagnoli, Valentina Isgrò, Fiorenzo Santoleri, Alberto Costantini

AboutOpen · 19.12.2025 · 12 (1) · 43-46

DOI: 10.33393/ao.2025.3645 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AboutOpen, online erschienen am 19.12.2025. Verfasst von Maurizio Polignano und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The European Medicines Agency (EMA) has updated its Reflection Paper on the use of Real-WorldData (RWD) in Observational Studies (OS), emphasizing the regulatory importance of Real-World Evidence (RWE).

Objectives

Summarize the main methodological recommendations of the EMA’s 2025 guidance, highlightchallenges and opportunities for the use of RWD in regulatory contexts, and discuss implications for clinicalresearchers, with particular attention to the role of pharmacists.

Discussion

The new guidance distinguishes descriptive from causal OS and endorses Target Trial Emulation (TTE)to improve causal inference in observational research. It stresses transparency, reproducibility, and rigorous datagovernance, while calling for robust strategies to manage bias and confounding. Pharmacists are recognized askey contributors to drug utilization research and post-marketing surveillance, ensuring data quality and interoperability and supporting the integration of RWE into regulatory decision-making.

Conclusions

EMA’s roadmap affirms the value of RWE in strengthening regulatory science. Its implementationwill require cultural change, technical expertise, and resource allocation, offering both challenges and opportunitiesfor healthcare researchers, particularly pharmacists, to transform RWD into trusted evidence.

Zitieren

APA

Polignano, M., Lasala, R., Giannini, R., Ucciero, A., Romagnoli, A., Isgrò, V., Santoleri, F., & Costantini, A. (2025). From data to evidence: the evolving role of observational studies and target trial emulation in regulatory decision-making. AboutOpen, 12(1), 43-46. https://doi.org/10.33393/ao.2025.3645

Vancouver

Polignano M, Lasala R, Giannini R, Ucciero A, Romagnoli A, Isgrò V, et al. From data to evidence: the evolving role of observational studies and target trial emulation in regulatory decision-making. AboutOpen. 2025;12(1):43-46. doi:10.33393/ao.2025.3645

BibTeX
@article{Polignano2025,
  author = {Polignano, Maurizio and Lasala, Ruggero and Giannini, Romina and Ucciero, Andrealuna and Romagnoli, Alessia and Isgrò, Valentina and Santoleri, Fiorenzo and Costantini, Alberto},
  title = {From data to evidence: the evolving role of observational studies and target trial emulation in regulatory decision-making},
  journal = {AboutOpen},
  year = {2025},
  volume = {12},
  number = {1},
  pages = {43--46},
  doi = {10.33393/ao.2025.3645}
}
Kostenlos starten →